Decker Stern Sadie sells 1466 Dexcom shares at $88.99 on July 28
PorAinvest
martes, 29 de julio de 2025, 4:23 pm ET1 min de lectura
DXCM--
The sale occurred pursuant to a 10b5-1 trading plan, which allows for the orderly disposition of shares owned by Ms. Stern. This plan is designed to facilitate the sale of shares without influencing the market price. The filing indicates that the sale was part of a broader strategy to manage Ms. Stern's holdings in the company [1].
According to the filing, the sale of 1,466 shares reduced Ms. Stern's beneficial ownership in DexCom to 106,689 shares. This represents a 10% decrease in her ownership stake, as she previously owned 118,155 shares [1].
The sale comes amidst a period of significant institutional activity in DexCom's stock. In the first quarter of 2025, Allianz Asset Management GmbH reduced its stake by 22.9%, while other institutional investors, such as Golden State Wealth Management LLC and Private Trust Co. NA, increased their holdings [2].
The recent insider selling activity at DexCom follows a trend of institutional investors adjusting their positions in the company. Over the last ninety days, insiders sold 27,190 shares of company stock valued at $2,281,732. Insiders now own 0.32% of the company's stock [2].
DexCom's stock performance has been mixed over the past year. The stock opened at $89.53 on Tuesday, July 2, 2025, and has a market cap of $35.11 billion. The company reported earnings per share of $0.32 for the most recent quarter, missing the consensus estimate of $0.33. However, the company's revenue for the quarter was up 12.5% year-over-year [2].
Analysts have provided a range of ratings and target prices for DexCom's stock. Four analysts have given a "hold" rating, fifteen have assigned a "buy" rating, and two have rated the stock as a "strong buy." The average rating is "Moderate Buy" with an average price target of $98.72 [2].
References:
[1] https://www.stocktitan.net/sec-filings/DXCM/form-4-dex-com-inc-insider-trading-activity-7870a73a6a13.html
[2] https://www.marketbeat.com/instant-alerts/filing-dexcom-inc-nasdaqdxcm-holdings-decreased-by-allianz-asset-management-gmbh-2025-07-29/
On July 28, 2025, DexCom Inc. (DXCM) announced that EVP, Chief HR Officer Sadie Stern sold 1,466 shares at a price of $88.99 per share.
On July 28, 2025, DexCom Inc. (DXCM) reported that EVP and Chief HR Officer Sadie Stern sold 1,466 shares of the company's stock at a price of $88.99 per share. The transaction was disclosed in a Form 4 filing with the U.S. Securities and Exchange Commission (SEC) [1].The sale occurred pursuant to a 10b5-1 trading plan, which allows for the orderly disposition of shares owned by Ms. Stern. This plan is designed to facilitate the sale of shares without influencing the market price. The filing indicates that the sale was part of a broader strategy to manage Ms. Stern's holdings in the company [1].
According to the filing, the sale of 1,466 shares reduced Ms. Stern's beneficial ownership in DexCom to 106,689 shares. This represents a 10% decrease in her ownership stake, as she previously owned 118,155 shares [1].
The sale comes amidst a period of significant institutional activity in DexCom's stock. In the first quarter of 2025, Allianz Asset Management GmbH reduced its stake by 22.9%, while other institutional investors, such as Golden State Wealth Management LLC and Private Trust Co. NA, increased their holdings [2].
The recent insider selling activity at DexCom follows a trend of institutional investors adjusting their positions in the company. Over the last ninety days, insiders sold 27,190 shares of company stock valued at $2,281,732. Insiders now own 0.32% of the company's stock [2].
DexCom's stock performance has been mixed over the past year. The stock opened at $89.53 on Tuesday, July 2, 2025, and has a market cap of $35.11 billion. The company reported earnings per share of $0.32 for the most recent quarter, missing the consensus estimate of $0.33. However, the company's revenue for the quarter was up 12.5% year-over-year [2].
Analysts have provided a range of ratings and target prices for DexCom's stock. Four analysts have given a "hold" rating, fifteen have assigned a "buy" rating, and two have rated the stock as a "strong buy." The average rating is "Moderate Buy" with an average price target of $98.72 [2].
References:
[1] https://www.stocktitan.net/sec-filings/DXCM/form-4-dex-com-inc-insider-trading-activity-7870a73a6a13.html
[2] https://www.marketbeat.com/instant-alerts/filing-dexcom-inc-nasdaqdxcm-holdings-decreased-by-allianz-asset-management-gmbh-2025-07-29/

Divulgación editorial y transparencia de la IA: Ainvest News utiliza tecnología avanzada de Modelos de Lenguaje Largo (LLM) para sintetizar y analizar datos de mercado en tiempo real. Para garantizar los más altos estándares de integridad, cada artículo se somete a un riguroso proceso de verificación con participación humana.
Mientras la IA asiste en el procesamiento de datos y la redacción inicial, un miembro editorial profesional de Ainvest revisa, verifica y aprueba de forma independiente todo el contenido para garantizar su precisión y cumplimiento con los estándares editoriales de Ainvest Fintech Inc. Esta supervisión humana está diseñada para mitigar las alucinaciones de la IA y garantizar el contexto financiero.
Advertencia sobre inversiones: Este contenido se proporciona únicamente con fines informativos y no constituye asesoramiento profesional de inversión, legal o financiero. Los mercados conllevan riesgos inherentes. Se recomienda a los usuarios que realicen una investigación independiente o consulten a un asesor financiero certificado antes de tomar cualquier decisión. Ainvest Fintech Inc. se exime de toda responsabilidad por las acciones tomadas con base en esta información. ¿Encontró un error? Reportar un problema

Comentarios
Aún no hay comentarios